JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vincent, J. L.
Right arrow Articles by Primo, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, J. L.
Right arrow Articles by Primo, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 33-39, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation

JL Vincent, E Carlier, MR Pinsky, J Goldstein, R Naeije, P Lejeune, S Brimioulle, JL Leclerc, RJ Kahn and G Primo
Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium.

The infusion of prostaglandin E1, a vasodilating substance with predominant effects on the pulmonary vasculature, has been found effective in the management of pulmonary hypertension associated with various diseases. The reported experience with prostaglandin E1 after cardiac transplantation is, however, limited. We used prostaglandin E1 in 18 patients in whom acute right ventricular failure developed after orthotopic cardiac transplantation. The infusion was started within 24 hours after operation in 16 patients and was continued for up to 7 days. Maximal doses of prostaglandin E1, administered via a central venous catheter, ranged from 30 to 120 ng/kg/min. Norepinephrine was simultaneously infused via a left atrial catheter in 10 patients to prevent a reduction in systemic arterial pressure. The prostaglandin E1 infusion resulted in significant reductions in mean arterial pressure and pulmonary vascular resistance and simultaneous increases in cardiac index and stroke index. Mean arterial pressure was stable and left ventricular stroke work increased. The alveolar oxygen tension/forced inspiratory oxygen index tended to decrease during the infusion. Three patients died, two of right heart failure and one of multiple organ failure associated with cardiac allograft rejection. In patients in whom right ventricular failure associated with pulmonary hypertension develops after cardiac transplantation, prostaglandin E1, combined with norepinephrine whenever the arterial pressure declines, can effectively reduce pulmonary artery pressures and improve global cardiac function without compromising systemic perfusion.


This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
I. M. Lang
Management of acute and chronic RV dysfunction
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H61 - H67.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Stobierska-Dzierzek, H. Awad, and R. E. Michler
The evolving management of acute right-sided heart failure in cardiac transplant recipients
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Rajek, T. Pernerstorfer, J. Kastner, P. Mares, M. Grabenwoger, D. I. Sessler, G. Grubhofer, and M. Hiesmayr
Inhaled Nitric Oxide Reduces Pulmonary Vascular Resistance More Than Prostaglandin E1 During Heart Transplantation
Anesth. Analg., March 1, 2000; 90(3): 523 - 530.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. J. Smith, M. P. Murphy, R. F. Appleyard, R. J. Rizzo, L. Aklog, R. G. Laurence, and L. H. Cohn
Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism
J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 800 - 806.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Roques, S. A. M. Nashef, X. Roques, M. A. Billes, and E. Baudet
Simultaneous norepinephrine-prostacyclin biatrial infusion for right ventricular failure after transplantation
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 647 - 648.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.